14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
RBA vs RGA: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 17, 2026, Reinsurance Group of America, Incorporated (RGA) is the stronger overall head-to-head candidate over RB Global, Inc. (RBA) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). RBA carries a Unified Composite Score of 35.5/100 (SELL) at $92.49 (19.5x Forward P/E, 17.3% operating margin), whereas RGA carries 42.0/100 (HOLD) at $269.55 (9.0x Forward P/E, 9.4% operating margin).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RBA vs RGA. Trailing 12-month operating profitability (RBA 17.3% vs RGA 9.4%) and valuation multiples (RBA 19.5x vs RGA 9.0x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Insurance - Reinsurance value chain with $17.9B market capitalization and 9.4% operating margin.
OpEx & R&D Reinvestment5.2% of Rev ($1.42B)
90D Engineering Disclosures0 Published
Investor FAQ RBA vs RGA Key Questions & Quantitative Answers
As of Nov 17, 2026, Reinsurance Group of America, Incorporated (RGA) is the stronger overall head-to-head candidate over RB Global, Inc. (RBA) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). RBA carries a Unified Composite Score of 35.5/100 (SELL) at $92.49 (19.5x Forward P/E, 17.3% operating margin), whereas RGA carries 42.0/100 (HOLD) at $269.55 (9.0x Forward P/E, 9.4% operating margin). Technically, RBA sits in a Markup phase (RSI 54.7, UNCLASSIFIED options structure) and RGA sits in a Markup phase (RSI 56.5, UNCLASSIFIED options structure).
RGA leads the Growth & Scale pillar: RBA posts +16.6% YoY revenue growth and +62.8% YoY earnings growth on $5.03B TTM revenue (45.4% gross margin, 17.3% operating margin), compared with RGA at +21.7% YoY revenue growth and +81.6% YoY earnings growth on $27.3B TTM revenue (14.6% gross margin, 9.4% operating margin). On trailing 12-month operating scale, RBA generates $5.03B in USD-normalized revenue versus $27.3B for RGA. In operating R&D and SG&A reinvestment, RBA deploys 28.1% of Rev ($1.41B) (0 90-day corporate R&D disclosures) versus 5.2% of Rev ($1.42B) (0 disclosures) for RGA.
RGA screens cheaper on headline valuation multiples. RBA trades at 19.5x Forward P/E, 36.7x Trailing P/E, 0.76x PEG, and 3.4x EV/Revenue (27.6% EBITDA margin), whereas RGA trades at 9.0x Forward P/E, 10.7x Trailing P/E, 1.14x PEG, and 0.7x EV/Revenue (9.6% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against RBA (9.0% ROE) versus RGA (13.9% ROE) capital efficiency.
In options market volatility and institutional positioning, RBA carries 27.2% implied volatility (3rd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.48β · 29% Vol realized risk). By comparison, RGA carries 22.4% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.20β · 20% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.